Medical Directives

Primary Prevention in CKDMoataz Daoud, Pharm D student+Learning ObjectivesOsteoporosisDifferentiate between Renal Osteodystrophy and OPIdentify management strategies for patients with CKDHyperuricemiaDescribe renal handling of urate during hyperuricemia and chronic kidney diseaseReview the evidence on the impact of hyperuricemia on renal disease

+http://www.slideshare.net/KMC127/nkf-infographic-shows-6-in-10-at-ckd-risk 2CKD in Canada2.6 million Canadians have CKD 2.2 million unaware they have kidney disease20, 000 Canadians require dialysis40% of people with diabetes will develop CKDDialysis costs ~ $60,000 per patient per year

http://www.slideshare.net/KMC127/nkf-infographic-shows-6-in-10-at-ckd-risk

+The estimated prevalence of stage 35 disease was 3.1% (0.73 million adults) and albuminuria 10.3% (2.4 million adults3Chronic Kidney DiseaseStageDescriptionGFR (mL/min)Prevalence (%)1Normal or GFR 90 3.32Mild GFR60-893.03AModerate GFR45-594.33B30-444Severe GFR15-290.25Kidney Failure